Clinical Trial Update: Optimize First-line Treatment for AL Amyloidosis With t (11; 14) [NA]

View source ↗

Summary

A clinical trial is ongoing to optimize first-line treatment for systemic AL amyloidosis with the t(11;14) translocation; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis
• Systemic Amyloidosis

Snippet

Sponsor: Jin Lu, MD | Conditions: Amyloidosis; Systemic, AL Amyloidosis | NA | Status: RECRUITING